BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22638857)

  • 1. Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility.
    Brubel R; Kiss P; Vincze A; Varga A; Varnagy A; Bodis J; Mark L; Jambor E; Maasz G; Hashimoto H; Helyes Z; Toth G; Tamas A; Koppan M; Reglodi D
    J Mol Neurosci; 2012 Nov; 48(3):623-30. PubMed ID: 22638857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient mice.
    Reglodi D; Cseh S; Somoskoi B; Fulop BD; Szentleleky E; Szegeczki V; Kovacs A; Varga A; Kiss P; Hashimoto H; Tamas A; Bardosi A; Manavalan S; Bako E; Zakany R; Juhasz T
    Reproduction; 2018 Feb; 155(2):129-139. PubMed ID: 29101268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Neuropeptides Pituitary Adenylate Cyclase Activating Polypeptide and Vasoactive Intestinal Peptide in Male Fertility.
    Bdeir R; Al-Keilani MS; Khamaiseh K
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674298
    [No Abstract]   [Full Text] [Related]  

  • 4. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PACAP-mediated sperm-cumulus cell interaction promotes fertilization.
    Tanii I; Aradate T; Matsuda K; Komiya A; Fuse H
    Reproduction; 2011 Feb; 141(2):163-71. PubMed ID: 21071464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry.
    Brubel R; Reglodi D; Jambor E; Koppan M; Varnagy A; Biro Z; Kiss P; Gaal V; Matkovits A; Farkas J; Lubics A; Bodis J; Bay C; Veszpremi B; Tamas A; Nemeth J; Mark L
    J Mass Spectrom; 2011 Feb; 46(2):189-94. PubMed ID: 21259400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro.
    Horvath G; Mark L; Brubel R; Szakaly P; Racz B; Kiss P; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Shintani N; Furjes G; Nemeth J; Reglodi D
    Neurosci Lett; 2010 Jan; 469(1):70-4. PubMed ID: 19932736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of pituitary adenylate cyclase activating polypeptide (PACAP) in human amniotic fluid samples.
    Toth D; Veszpremi B; Koppan M; Tamas A; Szogyi D; Brubel R; Nemeth J; Shams M; Reglodi D
    Reprod Biol; 2020 Dec; 20(4):491-495. PubMed ID: 32859528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Regulates the Hypothalamo-Pituitary-Thyroid (HPT) Axis via Type 2 Deiodinase in Male Mice.
    Egri P; Fekete C; Dénes Á; Reglődi D; Hashimoto H; Fülöp BD; Gereben B
    Endocrinology; 2016 Jun; 157(6):2356-66. PubMed ID: 27046436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury.
    Tsuchikawa D; Nakamachi T; Tsuchida M; Wada Y; Hori M; Farkas J; Yoshikawa A; Kagami N; Imai N; Shintani N; Hashimoto H; Atsumi T; Shioda S
    J Mol Neurosci; 2012 Nov; 48(3):508-17. PubMed ID: 22674051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus.
    Gaszner B; Kormos V; Kozicz T; Hashimoto H; Reglodi D; Helyes Z
    Neuroscience; 2012 Jan; 202():283-99. PubMed ID: 22178610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.
    Tamas A; Szabadfi K; Nemeth A; Fulop B; Kiss P; Atlasz T; Gabriel R; Hashimoto H; Baba A; Shintani N; Helyes Z; Reglodi D
    Neurotox Res; 2012 May; 21(4):435-44. PubMed ID: 22203609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk.
    Borzsei R; Mark L; Tamas A; Bagoly T; Bay C; Csanaky K; Banki E; Kiss P; Vaczy A; Horvath G; Nemeth J; Szauer E; Helyes Z; Reglodi D
    Eur J Endocrinol; 2009 Apr; 160(4):561-5. PubMed ID: 19174531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Involved in Adult Mouse Hippocampal Neurogenesis After Stroke.
    Matsumoto M; Nakamachi T; Watanabe J; Sugiyama K; Ohtaki H; Murai N; Sasaki S; Xu Z; Hashimoto H; Seki T; Miyazaki A; Shioda S
    J Mol Neurosci; 2016 Jun; 59(2):270-9. PubMed ID: 26910758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide promotes eccrine gland sweat secretion.
    Sasaki S; Watanabe J; Ohtaki H; Matsumoto M; Murai N; Nakamachi T; Hannibal J; Fahrenkrug J; Hashimoto H; Watanabe H; Sueki H; Honda K; Miyazaki A; Shioda S
    Br J Dermatol; 2017 Feb; 176(2):413-422. PubMed ID: 27453364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of pituitary adenylate cyclase activating polypeptide and its type I receptor in the rat kidney.
    Brubel R; Horvath G; Reglodi D; Lubics A; Tamas A; Kiss P; Laszlo E; Nemeth J; Mark L; Szakaly P
    Transplant Proc; 2011 May; 43(4):1297-9. PubMed ID: 21620115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
    Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H
    Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury.
    Szakaly P; Laszlo E; Kovacs K; Racz B; Horvath G; Ferencz A; Lubics A; Kiss P; Tamas A; Brubel R; Opper B; Baba A; Hashimoto H; Farkas J; Matkovits A; Magyarlaki T; Helyes Z; Reglodi D
    Neuropeptides; 2011 Apr; 45(2):113-21. PubMed ID: 21211837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.